(Q42444834)

English

Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise

scientific article published on July 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

Adam Steensberg

2

object named as

Adam Steensberg

0 references

author name string

Mark A Febbraio

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Adam Steensberg

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Rebecca L Starkie

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Glenn K McConell

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Bronwyn A Kingwell

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

939-944

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

The expression of TNF alpha by human muscle. Relationship to insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Tumor necrosis factor system in insulin resistance in gestational diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Interleukin-6 gene polymorphism and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Skeletal muscle perfusion in electrically induced dynamic exercise in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Maximal perfusion of skeletal muscle in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900105-7

7 January 2021

Identifiers

10.1016/S0026-0495(03)00105-7

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

release_5sb7mcko4jbyflm3sn5byetix4

1 reference

https://api.fatcat.wiki/v0/release/5sb7mcko4jbyflm3sn5byetix4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42444834&oldid=1957129423"